Cell Genesys (Nasdaq: CEGE) is focused on the development and commercialization of novel biological therapies for patients with cancer. The company's lead product platform is GVAX(R) immunotherapy for cancer, which holds the potential to treat multiple types of cancer including prostate cancer, leukemia, pancreatic cancer and lung cancer. Cell Genesys continues to hold an equity interest in its former subsidiary, Ceregene, Inc., which is developing gene therapies for neurodegenerative disorders. Cell Genesys is headquartered in South San Francisco, California, and has manufacturing operations in Hayward, California. For additional information, please visit the company's website at www.cellgenesys.com.
Track Topic
: rss
Topic: CEGE!!!!!!!!!!!!!!! I WOULD TAKE A LOOK INTO IT IF I WERE YOU
posts 1–2 of 2
Page
1
+0
permalink
permalink
Yawn... It's really too bad that a company like this will never go anywhere.
My Bike Is Faster Than Yours
posts 1–2 of 2
Page
1
This Topic Is Locked To Guest Posts
It's been a while since this topic was active, if you'd like to get it going again, please post as a registered member
